Re: Promissory Note
|
2
|
Zenith Epigenetics
|
Jan 30, 2021 05:21PM
|
Re: HL USA - Material or not?
|
2
|
Resverlogix Corp.
|
Apr 11, 2019 02:26PM
|
Re: Name Confusion
|
2
|
Zenith Epigenetics
|
Jul 29, 2020 03:20PM
|
Re: Shrinking MACE event rate
|
2
|
Resverlogix Corp.
|
Jan 20, 2019 04:42PM
|
Re: Our market cap has gone over $1 billion CAD....
|
2
|
Resverlogix Corp.
|
May 19, 2019 09:13PM
|
Re: Feb. 06, 2019 FMV ZENE!
|
2
|
Zenith Epigenetics
|
Feb 07, 2019 05:57PM
|
Re: Warrants conversion!
|
2
|
Resverlogix Corp.
|
Nov 27, 2019 12:03PM
|
Re: Zenith Shareholders
|
2
|
Zenith Epigenetics
|
Sep 01, 2021 11:01PM
|
Re: HL Acquires Additional Securities of RVX
|
2
|
Resverlogix Corp.
|
May 22, 2021 11:58AM
|
Re: PP
|
2
|
Zenith Epigenetics
|
Aug 26, 2020 05:12PM
|
Re: Book closes.....
|
2
|
Resverlogix Corp.
|
Jun 05, 2019 11:08AM
|
Re: RESVERLOGIX CORP.CODE OF BUSINESS CONDUCT AND ETHICS
|
2
|
Resverlogix Corp.
|
Sep 12, 2019 03:42PM
|
Re: RVX Long Covid Trial
|
2
|
Resverlogix Corp.
|
May 31, 2023 12:47PM
|
Filings extension
|
2
|
Zenith Epigenetics
|
Aug 26, 2020 06:07PM
|
Re: Insider activity, grants of rights and an option exercise at 75 cents
|
2
|
Resverlogix Corp.
|
Jun 16, 2019 01:58PM
|
Zenith A Loser Too
|
2
|
Zenith Epigenetics
|
Jun 16, 2020 01:38PM
|
Re: RVX Long Covid Trial
|
2
|
Resverlogix Corp.
|
May 28, 2023 01:01PM
|
Re: Saudi
|
2
|
Resverlogix Corp.
|
Jan 16, 2021 07:41PM
|
Re: Insider activity, grants of rights and an option exercise at 75 cents
|
2
|
Resverlogix Corp.
|
Jun 16, 2019 04:31PM
|
Re: Received a response....Third Eye Loan Balance
|
2
|
Resverlogix Corp.
|
Jul 14, 2019 02:50PM
|